Go Back

Imagine revenue management without the friction

FinThrive creates integrated technology that adapts with healthcare professionals – freeing them from complexity and inefficiency so they can focus on doing their best work. Our end-to-end revenue management platform provides financial teams and stakeholders with greater reliability and control to deliver better outcomes for everyone. With our vision, technology, experience and scale, we’re advancing the healthcare economy.

FinThrive

Healthcare

HIMSS 2024 with Nicole Clawson: The Future of Rural Healthcare

Brian Urban
May 3, 2024
Brian Urban
FinThrive
Healthcare Rethink podcast
HIMSS
+more

 

In this episode of Healthcare Rethink, conducted at HIMSS 2024, host Brian Urban engages with Nicole Clawson, the Vice President of Revenue Cycle and Finance at Pennsylvania Mountains Healthcare Alliance. They delve into pressing issues facing community hospitals and explore innovative solutions in rural healthcare settings.

The conversation covers a wide array of topics, including technology adoption, revenue cycle management, and the impact of social determinants on healthcare delivery in rural areas. Clawson shared her firsthand experiences and insights from overseeing 16 Pennsylvania and New York community hospitals. This episode offers a deep dive into the challenges and advancements in rural healthcare, providing listeners with valuable perspectives to drive change in their communities.

Nicole Clawson is crucial in steering Pennsylvania Mountains Healthcare Alliance toward innovative healthcare solutions. With a strong focus on improving access to quality care in rural communities, Nicole oversees the financial health and revenue cycles of 16 hospitals across Pennsylvania and New York. Her leadership and commitment to technological advancement and operational efficiency aim to enhance patient care and hospital sustainability. Nicole’s strategic initiatives in rural healthcare have significantly impacted, particularly in addressing unique challenges such as service availability, digital adoption, and economic sustainability.

Recent Episodes

vitro
View episode

Analyzing the Suppressive TME in In Vitro Based Assays

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

cancer
View episode

Targeting T Cells Within the Cancer Immunity Cycle

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

cancer Immunity cycle
View episode

Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert